Innovation
13 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 435 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 3 |
Social engagement
Social engagement: 10.5K social following, 8 posts in the last 12 months — around the industry typical range.
Investor mix
4 investors on record; lead investors include Qbic Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |
Recent activity
8 May 2026
Event
Live webinar featuring Co-founder and Chief Scientific Officer Iris Alroy and Chief Business Officer Generoso Ianniciello
17 Mar 2026
Event
Building New Bridges: Creating Win-Win Collaborations in Pharmatech
16 Dec 2025
Event
The Coming Disruption AI-first Summit